Recommended Set

21. Declaration of interests List all funding sources (including grant identifier) and the role of the funder(s) in the design, analysis, and reporting of the study. explanation

21a Declare any potential conflicts of interest, including financial and non-financial. If none exist, this should be stated.
21b List all funding sources (including grant identifier) and the role of the funder(s) in the design, analysis, and reporting of the study.
Explanation
Examples

The identification of funding sources allows the reader to assess any competing interests, and any potential sources of bias. For example, bias, as indicated by a prevalence of more favourable outcomes, has been demonstrated for clinical research funded by industry compared to studies funded by other sources [1-3]. Evidence for preclinical research also indicates that funding sources may influence the interpretation of study outcomes [4,5].

Report the funding information including the financial supporting body(s) and any grant identifier(s). If the study was supported by several sources of funding, list them all, including internal grants. Specify the role of the funder in the design, analysis, reporting and/or or decision to publish. If the research did not receive specific funding but was performed as part of the employment of the authors, name the employer.

 

References

  1. Lundh A, Sismondo S, Lexchin J, Busuioc OA and Bero L (2012). Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000033.pub2/full
  2. Popelut A, Valet F, Fromentin O, Thomas A and Bouchard P (2010). Relationship between Sponsorship and Failure Rate of Dental Implants: A Systematic Approach. PLOS ONE. doi: 10.1371/journal.pone.0010274
  3. Lexchin J, Bero LA, Djulbegovic B and Clark O (2003). Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Bmj. doi: 10.1136/bmj.326.7400.1167
  4. Krauth D, Anglemyer A, Philipps R and Bero L (2014). Nonindustry-Sponsored Preclinical Studies on Statins Yield Greater Efficacy Estimates Than Industry-Sponsored Studies: A Meta-Analysis. PLoS Biology. doi: 10.1371/journal.pbio.1001770
  5. Bero L, Anglemyer A, Vesterinen H and Krauth D (2016). The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis. Environment International. doi: 10.1016/j.envint.2015.10.011